<DOC>
	<DOCNO>NCT01541930</DOCNO>
	<brief_summary>This clinical trial objective investigate safety efficacy GK567 alleviate malodour foul smelling , anaerobically infected fungating neoplastic tumour , 14 day treatment . The clinical hypothesis success rate worse 70 % population interest , success patient define smell score 0 1 Day 14/end treatment , assess Study Investigator .</brief_summary>
	<brief_title>An Open , Uncontrolled Study GK567 Deodorization Malodorous Fungating Neoplastic Tumours</brief_title>
	<detailed_description />
	<mesh_term>Skin Ulcer</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>The subject male female age 20 year old . The subject cutaneous fungating neoplastic tumour smell suggest establish early infection , minimum score 2 ( i.e . mildly offensive smell ) 04 smell scale , ( base Study investigator 's assessment ) The subject currently receive systemic antibiotic receive last 2 week , The subject currently receive systemic topical Metronidazole receive last week , The subject currently receive topical antibiotic receive treatment apply cutaneous fungating neoplastic tumour last 1 week , The subject already receive topical treatment cutaneous fungating neoplastic tumour</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>